The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology


Trebicka J., Fernandez J., Papp M., Caraceni P., Laleman W., Gambino C., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.73, ss.842-854, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 73
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.jhep.2020.06.013
  • Dergi Adı: JOURNAL OF HEPATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.842-854
  • Anahtar Kelimeler: Chronic liver disease, Non-elective admission, Acute complications, Outcome, Risk factors, CHRONIC LIVER-FAILURE, INFLAMMATION, MORTALITY, SCORE
  • Marmara Üniversitesi Adresli: Evet

Özet

Background & Aims: Acute decompensation (AD) of cirrhosis is defined as the acute development of ascites, gastrointestinal hemorrhage, hepatic encephalopathy, infection or any combination thereof, requiring hospitalization. The presence of organ failure(s) in patients with AD defines acute-on-chronic liver failure (ACLF). The PREDICT study is a European, prospective, observational study, designed to characterize the clinical course of AD and to identify predictors of ACLF.